Blade Air Mobility Inc Stock Price, News & Analysis

Blade Air Mobility (NASDAQ:BLDE) announced Q2 2025 results and a major strategic transformation. The company will sell its Passenger division to Joby Aviation for up to $125 million, while its Medical division will remain a standalone public company rebranded as Strata Critical Medical.

Q2 2025 highlights include total revenue growth of 4.2% to $70.8 million, with Medical revenue increasing 17.6% to $45.1 million. Net loss improved by $7.6 million to $(3.7) million, and Adjusted EBITDA increased by $2.2 million to $3.2 million. The company ended Q2 with $113.4 million in cash and short-term investments.

Post-divestiture, Strata will operate as a pure-play healthcare solutions business, maintaining access to Joby's eVTOLs for medical use through a long-term partnership. The transaction is expected to be Adjusted EBITDA and Free Cash Flow neutral.

Blade Air Mobility (NASDAQ:BLDE) has announced the sale of its passenger division to Joby Aviation (NYSE:JOBY) for up to $125 million. Following the transaction, Blade will rebrand as Strata Critical Medical, focusing exclusively on medical logistics and services through its Trinity Medical Solutions subsidiary.

The deal includes Blade's US and European passenger operations, lounges, terminals, and brand rights. Post-transaction, Strata will maintain access to Joby's eVTOL aircraft for medical flights through a long-term partnership. The divestiture is expected to be Adjusted EBITDA and Free Cash Flow neutral, with $7 million in annual corporate cost efficiencies.

Leadership changes include current CEO Rob Wiesenthal joining Joby as Blade Air Mobility CEO, while Will Heyburn and Melissa Tomkiel will become Co-CEOs of Strata. The medical division represented 84% of 2024 Segment Adjusted EBITDA and 59% of Revenue.

Joby Aviation (NYSE:JOBY) has announced a strategic acquisition of Blade Air Mobility's passenger business for up to $125 million. The deal provides Joby with immediate access to Blade's extensive urban air mobility infrastructure, including 12 urban terminals across key markets in the U.S. and Europe.

The acquisition includes Blade's entire passenger operations, brand, and network of terminals, notably in New York City with locations at JFK, Newark, Manhattan's West and East sides, and Wall Street. Blade's Medical division will remain separate but partner with Joby for medical transportation. Blade's CEO Rob Wiesenthal will continue leading the passenger business as a Joby subsidiary.

This strategic move positions Joby for its commercial launch in Dubai next year and supports its global rollout plans. The company will leverage Blade's existing infrastructure and 50,000+ passenger base from 2024 to accelerate its transition from conventional helicopters to electric air taxis.

Blade Air Mobility (NASDAQ:BLDE) has scheduled its second quarter 2025 earnings conference call for Tuesday, August 5, 2025, at 8:00 am Eastern Time, following the release of financial results before market opens.

The conference call will feature CEO Rob Wiesenthal and CFO Will Heyburn, including a Q&A session. Interested participants can register to receive dial-in details and a unique PIN. The company will also provide an audio webcast accessible through their investor relations website, with a replay available for one year.

Blade Air Mobility (NASDAQ: BLDE) made history by participating in the first passenger-carrying electric aircraft flight in the U.S. The flight, operated by BETA Technologies' ALIA CTOL aircraft, successfully traveled from East Hampton Airport to JFK International Airport in New York. Blade CEO Rob Wiesenthal was a passenger on this groundbreaking flight, demonstrating the company's commitment to electric aviation. The ALIA CTOL, a battery-powered fixed-wing aircraft, has already logged thousands of miles and received an FAA market survey certificate. This milestone flight showcases the viability of electric aviation in metropolitan areas and positions Blade's asset-light model and terminal infrastructure to accelerate the transition to emission-free aircraft operations.

Blade Air Mobility (NASDAQ: BLDE), a technology-powered air mobility platform, has announced its participation in the upcoming Jefferies eVTOL / AAM Summit. The company's CEO Rob Wiesenthal and CFO Will Heyburn will deliver a presentation on Wednesday, May 28, 2025, at 10:40 AM ET. Interested parties can access the presentation through a webcast, with a replay available afterward on the company's investor relations website at ir.blade.com/news-events.

Blade Air Mobility (NASDAQ: BLDE), a technology-powered air mobility platform, has announced that CEO Rob Wiesenthal will deliver a presentation at the upcoming Ladenburg Thalmann Technology Innovation Expo 25. The presentation is scheduled for Wednesday, May 21, 2025, at 3:00 PM ET. Interested parties can access the presentation through a webcast, and a replay will be made available on the company's investor relations website at ir.blade.com/news-events shortly after the event concludes.

Blade Air Mobility (NASDAQ: BLDE), a technology-powered air mobility platform, has announced its participation in the 2025 J.P. Morgan Annual Global Technology, Media, and Communications Conference. Mat Schneider, Vice President of Investor Relations and Strategic Finance, will deliver a presentation on Wednesday, May 14, 2025, at 3:40 PM ET. The presentation will be accessible via webcast, with a replay available afterward on the company's investor relations website at ir.blade.com/news-events.

Blade Air Mobility (NASDAQ: BLDE) reported Q1 2025 financial results showing improved performance. Revenue increased 5.4% to $54.3 million, with a 10.9% growth excluding Canada operations. Net loss improved to $(3.5) million, a $0.7 million improvement year-over-year. The company achieved its first Adjusted EBITDA profitable Q1 in the Passenger Segment since going public, with Passenger Segment revenue growing 42% year-over-year excluding Canada. Medical segment showed stability with a slight revenue decrease of 0.2% to $35.9 million. The company maintained strong liquidity with $120 million in cash and short-term investments and reaffirmed its 2025 guidance, expecting revenue of $245-265 million with double-digit Adjusted EBITDA.